P-459 Impact on quality of life (COL) of patients (pts) with non small cell lung cancer (NSCLC) treated with paclitaxel/carboplatino (TXL/CP) as first line chemotherapy (CT)

Autor:	M. Andrada, P. Alvarez, D. Lewi, N. Villagra, S. Alberto, N. Mohr, G. Fiore, E. Korbenfeld, L. Kaen, S. Bonicatto
Rok vydání:	2005
Předmět:	Pulmonary and Respiratory Medicine Oncology Cancer Research medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) medicine.disease chemistry.chemical_compound Paclitaxel chemistry Quality of life Internal medicine medicine First line chemotherapy business
Zdroj:	Lung Cancer. 49:S237
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(05)80952-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5f2ea6ddfec04c4a57645d5293936960 https://doi.org/10.1016/s0169-5002(05)80952-3 Zobrazit plný text záznamu Full Text from ScienceDirect